Chronic Myelomonocytic Leukemia Completed Phase 1 Trials for Belinostat (DB05015)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00351975Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesTreatment